The ErbB signaling network: Receptor heterodimerization in development and cancer

EMBO Journal

Volumn 19, Issue 13, 2000, Pages 3159-3167

  Olayioye, Monilola A ^a   Neve, Richard M ^a,b   Lane, Heidi A ^a   Hynes, Nancy E ^a  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; EGF related growth factors; Mammary gland development; Receptor tyrosine kinases; Signal transduction cascades

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR;

BREAST CANCER; BREAST CARCINOGENESIS; DIMERIZATION; HUMAN; HUMAN CELL; MAMMARY GLAND; PRIORITY JOURNAL; REVIEW;

ANIMALS; BREAST NEOPLASMS; DIMERIZATION; HUMANS; LIGANDS; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION;

EID: 0034600849     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (126)

1. Alimandi, M., Romano, A., Curia, M.C., Muraro, R., Fedi, P., Aaronson, S.A., Di Fiore, P.P. and Kraus, M.H. (1995) Cooperative signaling of ErbB3 and ErbB2 in neoplaslic transformation. Oncogene, 10, 1813-1821.
2. Aroian, R.V., Koga, M., Mendel, J.E., Ohshima, Y. and Sternberg, P.W. (1990) The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor family. Nature, 348, 693-699.
3. Barbacci, E.G., Guarino, B.C., Stroh, J.G., Singleton, D.H., Rosnack, K.J., Moyer, J.D. and Andrews, G.C. (1995) The structure basis for the specificity of epidermal growth factor and heregulin binding. J. Biol. Chem., 270, 9585-9589.
4. Bargmann, C.I., Hung, M.C. and Weinberg, R.A. (1986) Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell, 45, 649-657.
5. Baselga, J. et al. (1996) Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol., 14, 737-744.
6. Batzer, A.G., Rotin, D., Urena, J.M., Skolnik, E.Y. and Schlessinger, J. (1994) Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptor. Mol. Cell. Biol., 14, 5192-5201.
7. Baulida, J., Kraus, M.H., Alimandi, M. Di Fiore, P.P. and Carpenter, G. (1996) All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem., 271, 5251-5257.
8. Beerli, R.R. and Hynes, N.E. (1996) Epidermal growth factor-related peptides activate distinct subsets of erbB receptors and differ in their biological activities. J. Biol. Chem., 271, 6071-6076.
9. Beerli, R.R., Wels, W. and Hynes, N.E. (1994) Intracellular expression of single chain antibodies reverts ErbB-2 transformation. J. Biol. Chem., 269, 23931-23936.
10. Beerli, R.R., Graus-Porta, D., Woods-Cook, K., Chen, X., Yarden, Y. and Hynes, N.E. (1995) Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol. Cell. Biol., 15, 6496-6505.
11. Biscardi, J.S., Maa, M.C., Tice, D.A., Cox, M.E., Leu, T.H. and Parsons, S.J. (1999a) c-Src-mediated phosphorylation of the EGF receptor on Tyr845 and Tyrl101 is associated with modulation of receptor function. J. Biol. Chem., 274, 8335-8343.
12. Biscardi, J.S., Tice, D.A. and Parsons, S.J. (1999b) c-Src, receptor tyrosine kinases and human cancer. Adv. Cancer Res., 76, 61-117.
13. Bodey, B., Bodey, B., Jr, Groger, A.M., Luck, J.V., Siegel, S.E., Taylor, C.R. and Kaiser, H.E. (1997) Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. Anticancer Res., 17, 1319-1330.
14. Britsch, S., Li, L., Kirchhoff, S., Theuring, F., Brinkmann, V., Birchmeier, C. and Riethmacher, D. (1998) The ErbB2 and ErbB3 receptors and their ligand, neuregulin-1, are essential for development of the sympathetic nervous system. Genes Dev., 12, 1825-1836.
15. Busfield, S.J. et al. (1997) Characterization of a neuregulin-related gene, Don-1, that is highly expressed in restricted regions of the cerebellum and hippocampus. Mol. Cell. Biol., 17, 4007-4014.
16. Carpenter, G. (1999) Employment of the epidermal growth factor receptor in growth factor-independent signaling pathways. J. Cell Biol., 146, 697-702.
17. Carraway, K.L., III, Weber, J.L., Unger, M.J., Ledesma, J., Yu, N., Gassmann, M. and Lai, K. (1997) Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature, 387, 512-516.
18. Chang, H., Riese, D.J., II, Gilbert, W., Stern, D.F. and McMahan, U.J. (1997) Ligands for ErbB-family receptors encoded by a neuregulin-like gene. Nature, 387, 509-512.
19. Chattopadhyay, A., Vecchi, M., Ji, Q., Mernaugh, R. and Carpenter, G. (1999) The role of individual SH2 domains in mediating association of phospholipase C-γ1 with the activated EGF receptor. J. Biol. Chem., 274, 26091-26097.
20. Cobleigh, M.A. et al. (1999) Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol., 17, 2639-2648.
21. Cohen, B.D., Kiener, P.A., Green, J.M. Foy, L., Fell, P. and Zhang, K. (1996a) The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J. Biol. Chem., 271, 30897-30903.
22. Cohen, B.D., Green, J.M., Foy, L. and Fell, H.P. (1996b) HER4-mediated biological and biochemical properties in NIH3T3 cells. J. Biol. Chem., 271, 4813-4818.
23. Dankort, D.L., Wang, Z., Blackmore, V., Moran, M.F. and Muller, W.J. (1997) Distinct tyrosine autophosphorylation sites negatively and positively modulate Neu-mediated transformation. Mol. Cell. Biol., 17, 5410-5425.
24. Darcy, K.M., Zangani, D., Wolhueter, A.L., Huang, R.Y., Vaughan, M.M., Russell, J.A. and Ip, M.M. (2000) Changes in ErbB2 (HER2/neu), ErbB3 and ErbB4 during growth, differentiation and apoptosis of normal rat mammary epithelial cells. J. Histochem. Cytochem., 48, 63-80.
25. DiGiovanna, M.P., Lerman, M.A., Coffey, R.J., Muller, W.J., Cardiff, R.D. and Stern, D.F. (1998) Active signaling by Neu in transgenic mice. Oncogene, 17, 1877-1884.
26. Downward, J., Parker, P. and Waterfield, M.D. (1984) Autophosphorylation sites on the epidermal growth factor receptor. Nature, 311, 483-485.
27. Elenius, K., Choi, C.J., Paul, S., Santiestevan, E., Nishi, E. and Klagsbrun, M. (1999) Characterization of a naturally occurring ErbB4 isoform that does not bind or activate phosphatidyl inositol 3-kinase. Oncogene, 18, 2607-2615.
28. Erickson, S.L., O'Shea, K.S., Ghaboosi, N., Loverro, L., Frantz, G., Bauer, M., Lu, L.H. and Moore, M.W. (1997) ErbB3 is required for normal cerebellar and cardiac development: a comparison with ErbB2-and heregulin-dertcient mice. Development, 124, 4999-5011.
29. Fazioli, F., Minichiello, L., Matoskova, B., Wong, W.T. and Di Fiore, P.P. (1993) Eps15, a novel tyrosine kinase substrate, exhibits transforming activity. Mol. Cell. Biol., 13, 5814-5828.
30. Fiddes, R.J., Campbell, D.H., Janes, P.W., Sivertsen, S.P., Sasaki, H., Wallasch, C. and Daly, R.J. (1998) Analysis of Grb7 recruitment by heregulin-activated erbB3 receptors reveals a novel target selectivity for erbB3. J. Biol. Chem., 273, 7717-7724.
31. Fowler, K.J. et al. (1995) A mutation in the epidermal growth factor receptor in waved-2 mice has a profound effect on receptor biochemistry that results in impaired lactation. Proc. Natl Acad. Sci. USA, 92, 1465-1469.
32. French, A.R., Tadaki, D.K., Niyogi, S.K. and Lauffenburger, D.A. (1995) Intracellular trafficking of epidermal growth factor family ligands is directly influenced by the pH sensitivity of the receptor/ligand interaction. J. Biol. Chem., 270, 4334-4340.
33. Gassmann, M., Casagranda, F., Orioli, D., Simon, H., Lai, C., Klein, R. and Lemke, G. (1995) Aberrant neural and cardiac development in mice lacking the erbB4 neuregulin receptor. Nature, 378, 390-394.
34. Gilbertson, R.J., Perry, R.H., Kelly, P.J., Pearson, A.D.J. and Lunee, J. (1997) Prognostic significance of HER2 and HER4 co-expression in childhood medulloblastoma. Cancer Res., 57, 3272-3280.
35. Graus-Porta, D., Beerli, R.R. and Hynes, N.E. (1995) Single-chain antibody-mediated intracellular retention of ErbB-2 impairs Neu differentiation factor and epidermal growth factor signaling. Mol. Cell. Biol., 15, 1182-1191.
36. Graus-Porta, D., Beerli, R.R., Daly, J.M. and Hynes, N.E. (1997) ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J., 16, 1647-1655.
37. Groenen, L.C., Nice, E.C. and Burgess, A.W. (1994) Structure-function relationships for the EGF/TGF-α family of mitogens. Growth Factors, 11, 235-257.
38. ErbB3 possesses an impaired tyrosine kinase activity. Proc. Natl Acad. Sci. USA, 91, 8132-8136.
39. Hackel, P.O., Zwick, E., Prenzel, N. and Ullrich, A. (1999) Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr. Opin. Cell Biol., 11, 184-189.
40. Harari, D., Tzahar, E., Romano, J., Shelly, M., Pierce, J.H., Andrews, G.C. and Yarden, Y. (1999) Neuregulin-4: a novel growth factor that acts through the ErbB-4 receptor tyrosine kinase. Oncogene, 18, 2681-2689.
41. Hazan, R., Margolis, B., Dombalagian, M., Ullrich, A., Zilberstein, A. and Schlessinger, J. (1990) Identification of autophosphorylation sites of HER2/neu. Cell Growth Differ., 1, 3-7.
42. Heldin, C.-H. (1995) Dimerization of cell surface receptors in signal transduction. Cell, 80, 213-223.
43. Hennighausen, L. and Robinson, G.W. (1998) Think globally, act locally: the making of a mouse mammary gland. Genes Dev., 12, 449-455.
44. Hsuan, J.J., Totty, N. and Waterfield, M.D. (1989) Identification of a novel autophosphorylation site (P4) on the epidermal growth factor receptor. Biochem. J., 262, 659-663.
45. HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol. Cell. Biol., 9, 1165-1172.
46. Hynes, N.E. and Stern, D.F. (1994) The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. Biophys. Acta, 1198, 165-184.
47. Jannot, C.B., Beerli, R.R., Mason, S., Gullick, W.J. and Hynes, N.E. (1996) Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells. Oncogene, 13, 275-282.
48. Joazeiro, C.A.P., Wing, S.S., Huang, H.K., Leverson, J.D., Hunter, T. and Liu, Y.C. (1999) The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science, 286, 309-311.
49. Jones, F.E. and Stern, D.F. (1999) Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Oncogene, 18, 3481-3490.
50. Jones, F.E., Welte, T., Fu, X.Y. and Stern, D.F. (1999) ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation. J. Cell Biol., 147, 77-87.
51. Jones, J.Y., Akita, R.W. and Sliwkowski, M.X. (1999) Binding specificities and affinities of egf domains for ErbB receptors. FEBS Lett., 447, 227-231.
52. Karunagaran, D., Tzahar, E., Beerli, R.R., Chen, X., Graus-Porta, D., Ratzkin, B.J., Seger, R., Hynes, N.E. and Yarden, Y. (1996) ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264.
53. Katsuura, M. and Tanaka, S. (1989) Topographic analysis of human epidermal growth factor by monospecific antibodies and synthetic peptides. J. Biochem., 106, 87-92.
54. Keilhack, H., Tenev, T., Nyakatura, E., Godovac-Zimmermann, J., Nielsen, L., Seedorf, K. and Bohmer, F.D. (1998) Phosphotyrosine 1173 mediates binding of the protein-tyrosine phosphatase SHP-1 to the epidermal growth factor receptor and attenuation of receptor signaling. J. Biol. Chem., 273, 24839-24846.
55. c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell, 58, 287-292.
56. Kramer, R., Bucay, B., Kane, D.J., Martin, L.E., Tarpley, J.E. and Theill, L.E. (1996) Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc. Natl Acad. Sci. USA, 93, 4833-4838.
57. Kip1/Cdk2 complex formation: receptor overexpression does not determine growth dependency. Mol. Cell. Biol., 20, 3210-3223.
58. Lee, K.F., Simon, H., Chen, H., Bates, B., Hung, M.C. and Hauser, C. (1995) Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature, 378, 394-398.
59. Lemmon, M.A., Bu, Z., Ladbury, J.E., Zhou, M., Pinchasi, D., Lax, I., Engelman, D.M. and Schlessinger, J. (1997) Two EGF molecules contribute additively to stabilization of the EGFR dimer. EMBO J., 16, 281-294.
60. Lemoine, N.R., Barnes, D.M., Hollywood, D.P., Hughes, C.M., Smith, P., Dublin, E., Prigent, S.A., Gullick, W.J. and Hurst, H.C. (1992) Expression of the c-erbB3 gene product in breast cancer. Br. J. Cancer, 66, 1116-1121.
61. Lesa, G.M. and Sternberg, P.W. (1997) Positive and negative tissue-specific signaling by a nematode epidermal growth factor receptor. Mol. Biol. Cell, 8, 779-793.
62. Levkowitz, G., Klapper, L.N., Tzahar, E., Freywald, A., Sela, M. and Yarden, Y. (1996) Coupling of the c-Cbl protooncogene product to ErbB-1/EGF-receptor but not to other ErbB proteins. Oncogene, 12, 1117-1125.
63. Levkowitz, G. et al. (1999) Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by c-Cbl/Sli-1. Mol. Cell, 4, 1029-1040.
64. HER2 monoclonal antibodies. Cancer Immunol. Immunother., 37, 255-263.
65. Lewis, G.D., Lofgren, J.A., McMurtrey, A.E., Huijens, A., Fendly, B.M., Bauer, K.D. and Sliwkowski, M.X. (1996) Growth regulation of human breast and ovarian tumor cells by heregulin: evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness. Cancer Res., 56, 1457-1465.
66. Luetteke, N.C., Qiu, T.H., Fenton, S.E., Troyer, K.L., Riedel, R.F., Chang, A. and Lee, D.C. (1999) Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF ligands in mouse mammary gland development. Development, 126, 2739-2750.
67. Luttrell, L.M., Daaka, Y. and Lefkowitz, R.J. (1999) Regulation of tyrosine kinase cascades by G-protein coupled receptors. Curr. Opin. Cell Biol., 11, 177-183.
68. Margolis, B.L., Lax, I., Kris, R., Dombalagian, M., Honegger, A.M., Howk, R., Givol, D., Ullrich, A. and Schlessinger, J. (1989) All autophosphrylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyl-terminal tails. Identification of a novel site in EGF receptor. J. Biol. Chem., 264, 10667-10671.
69. Massague, J. and Pandiella, A. (1993) Membrane anchored growth factors. Annu. Rev. Biochem., 62, 515-541.
70. Meisner, H., Daga, A., Buxton, J., Fernandez, B., Chawla, A., Banerjee, U. and Czech, M.P. (1997) Interactions of Drosophila Cbl with epidermal growth factor receptors and role of Cbl in R7 photoreceptor cell development. Mol. Cell. Biol., 17, 2217-2225.
71. Meyer, D. and Birchmeier, C. (1995) Multiple essential functions of neuregulin in development. Nature, 378, 386-390.
72. Miettinen, P.J., Berger, J.E., Meneses, J., Phung, P., Pedersen, R.A., Werb, Z. and Derynk, R. (1995) Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature, 376, 337-341.
73. Morris, J.K., Weichun, L., Hauser, C., Marchuk, Y., Getman, D. and Lee, K.F. (1999) Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development. Neuron, 23, 273-283.
74. 1 cell cycle regulators in breast tumour cells. Oncogene, 19, 1647-1656.
75. Ojeda, J. and Ma, Y.J. (1999) Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J. Neurobiol., 40, 528-540.
76. Okabayashi, Y., Kido, Y., Okutani, T., Sugamoto, Y., Sakaguchi, K. and Kasuga, M. (1994) Tyrosine 1148 and 1173 of activated human epidermal growth factor receptors are binding sites of Shc in intact cells. J. Biol. Chem., 269, 18674-18678.
77. Okutani, T., Okabayashi, Y., Kido, Y., Sugimoto, Y., Sakaguchi, K., Matuoka, K., Takenawa, T. and Kasuga, M. (1994) Grb2/Ash binds directly to tyrosines 1068 and 1086 and indirectly to tyrosine 1148 of activated human epidermal growth factor receptor in intact cells. J. Biol. Chem., 269, 31310-31314.
78. Olayioye, M.A., Graus-Porta, D., Beerli, R.R., Rohrer, J., Gay, B. and Hynes, N.E. (1998) ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. Cell. Biol., 18, 5042-5051.
79. Olayioye, M.A., Beuvink, I., Horsch, K., Daly, J.M. and Hynes, N.E. (1999) ErbB receptor-induced activation of Stat transcription factors is mediated by Src tyrosine kinases. J. Biol. Chem., 274, 17209-17218.
80. Paria, B.C, Elenius, K., Klagsbrun, M. and Dey, S.K. (1999) Heparin-binding EGF-like growth factor interacts with mouse blastocysts independently of ErbBl: a possible role for heparan sulfate proteoglycans and ErbB4 in blastocyst implantation. Development, 126, 1997-2005.
81. Pegram, M.D. et al. (1998) Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment. J. Clin. Oncol., 16, 2659-2671.
82. Peles, E. and Yarden, Y. (1993) Neu and its ligands: from an oncogene to neural factors. BioEssay, 15, 815-824.
83. Pinkas-Kramarski, R. et al. (1996) Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO J., 15, 2452-2467.
84. Prigent, S.A. and Gullick, W. (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′-kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO J., 13, 2831-2841.
85. Rajkumar, T., Stamp, G.W.H., Pandha, H.S., Waxman, J. and Gullick, W.J. (1996) Expression of the type 1 tyrosine kinase growth factor EGF receptors c-erbR-2 and c-erbB-3 in bladder cancer. J. Pathol., 179, 381-385.
86. Ricci, A., Lanfrancone, L., Chiari, R., Belardo, G., Pertica, C., Natali, P.G., Pelicci, P.G. and Segatto, O. (1995) Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathways by the ErbB-2 kinase. Oncogene, 11, 1519-1529.
87. Riese, D.J., II and Stern, D.F. (1998) Specificity within the EGF family/ErbB receptor family signaling network. BioEssays, 20, 41-48.
88. Riese, D.J., II, van Raaij, T.M., Plowman, G.D., Andrews, G.C. and Stern, D.F. (1995) The cellular response to neregulins is governed by complex interactions of the erbB receptor family. Mol. Cell. Biol., 15, 5770-5776.
89. Riese, D.J., II, Bermingham, Y., van Raaij, T.M., Buckley, S., Plowman, G.D. and Stern, D.F. (1996) Betacellin activates the epidermal growth factor receptor and ErbB4 and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-β. Oncogene, 12, 345-353.
90. Riethmacher, D., Sonnenberg-Riethmacher, E., Brinkmann, V., Yamaai, T., Lewin, G.R. and Birchneier, C. (1995) Severe neuropathies in mice with targeted mutations in the erbB3 receptor. Nature, 389, 725-730.
91. Rotin .D. et al. (1992) SH2 domains prevent tyrosine phosphorylation of the EGF receptor: identification of Tyr992 as the high-affinity binding site for SH2 domains of phospholipase Cγ EMBO J., 11, 559-567.
92. Sakaguchi, K., Okabayashi, Y., Kido, Y., Kimura, S., Matsumura, Y., Inushima, K. and Kasuga, M. (1998) Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates ras activation in intact cells. Mol. Endocrinol., 12, 536-543.
93. Salomon, D.S., Brandt, R., Ciardiello, F. and Normanno, N. (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit. Rev. Oncol. Hematol., 19, 183-232.
94. Sato, K., Sato, A., Aoto, M. and Fukami, Y. (1995) c-Src phosphorylates EGF receptor on tyrosine 845. Biochem. Biophys. Res. Commun., 215, 1078-1087.
95. Schroeder, J.A. and Lee, D.C. (1998) Dynamic expression and activation of ERBB receptors in the developing mouse mammary gland. Cell Growth Differ., 9, 451-164.
96. Segatto, O., Lonardo, F., Pierce, J.H., Bottaro, D.P. and Di Fiore, P.P. (1990) The role of autophosphorylation in modulation of erbB-2 transforming function. New Biol., 2, 187-195.
97. 1-phase progression. Genes Dev., 13, 1501-1512.
98. Shoelson, S.E. (1997) SH2 and PTB domain interactions in tyrosine kinase signal transduction. Curr. Opin. Chem. Biol., 1, 227-234.
99. Sibilia, M. and Wagner, E.F. (1995) Strain-dependent epithelial defects in mice lacking the EGF receptor. Science, 269, 234-238.
100. Sibilia, M., Steinbach, J.P., Stingl, L., Aguzzi, A. and Wagner, E.F. (1998) A strain-dependent postnatal neurodegeneration in mice lacking EGF receptor. EMBO J., 17, 719-731.
101. Siegel, P.M., Ryan, E.D., Cardiff, R.D. and Muller, W. (1999) Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J., 18, 2149-2164.
102. Slamon, D.J. et al. (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712.
103. Spencer, K.S.R., Graus-Porta, D., Leng, J., Hynes, N.E. and Klemke, R.L. (2000) ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases. J. Cell Biol., 148, 385-397.
104. Stover, D.R., Becker, M., Liebetanz, J. and Lydon, N.B. (1995) Src phosphorylation of the epidermal growth factor receptor at novel sites mediates receptor interaction with Src and p85α. J. Biol. Chem., 270, 15591-15597.
105. Sudol, M. (1998) From Src homology domains to other signaling modules: proposal of the 'protein recognition code'. Oncogene, 17, 1469-1474.
106. Tang, C.K. and Lippman, M.E. (1998) EGF family receptors and their ligands in human cancer. In O'Malley, B.W. (ed.), Hormones and Signaling, Vol. I. Academic Press, San Diego, CA, pp. 113-165.
107. Threadgill, D.W. et al. (1995) Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science, 269, 230-234.
108. Torrisi, M.R., Lotti, L.V., Belleudi, F. Gradini, R., Salcini, A.E., Confalonieri, S., Pelicci, P.G. and Di Fiore, P.P. (1999) Eps15 is recruited to the plasma membrane upon epidermal growth factor receptor activation and localizes to components of the endocytic pathway during receptor internalization. Mol. Biol. Cell, 10, 417-434.
109. Toyoda, H., Komurasaki, T., Uchida, D. and Morimoto, S. (1997) Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J., 326, 69-75.
110. Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B.J. and Yarden, Y. (1996) A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol., 16, 5276-5287.
111. Tzahar, E. et al. (1997) Bivalence of EGF-like ligands drives the ErbB signaling network. EMBO J., 16, 4938-4950.
112. Tzahar, E. et al. (1998) Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J., 17, 5948-5963.
113. Wallasch, C., Weiss, F.U., Niederfellner, G., Jallal, B., Issing, W. and Ullrich, A. (1995) Heregulin-dependent regulation of HER2/neu oncogenic signaling by heterodimerization with HER3. EMBO J., 14, 4267-4275.
114. Walton, G.M., Chen, W.S., Rosenfeld, M.G. and Gill, G.N. (1990) Analysis of deletions of the carboxyl terminus of the EGFR reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J. Biol. Chem., 265, 1750-1754.
115. Wasserman, J.D. and Freeman, M. (1997) Control of EGF receptor activation in Drosophila. Trends Cell Biol., 7, 431-436.
116. Waterman, H., Sabanai, I., Geiger, B. and Yarden, Y. (1998) Alternative intracellular routing of ErbB receptors may determine signaling potency. J. Biol. Chem., 273, 13819-13827.
117. Weiner, D.B., Liu, J., Cohen, J.A., Williams, W.V. and Greene, M.I. (1989) A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature, 339, 230-231.
118. Weiss, A. and Schlessinger, J. (1998) Switching signals on or off by receptor dimerization. Cell, 94, 277-280.
119. Wiesen, J.F., Young, P., Werb, Z. and Cunha, G.R. (1999) Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development, 126, 335-344.
120. Xie, W., Paterson, A.J., Chin, E., Nabell, L.M. and Kudlow, J.E. (1997) Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol., 11, 1766-1781.
121. Yang, Y., Spitzer, E., Meyer, D., Sachs, M., Niemann, C., Hartmann, G., Weidner, K.M., Birchmeier, C. and Birchmeier, W. (1995) Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol., 131, 215-226.
122. Yokouchi, M., Kondo, T., Houghton, A., Bartkiewicz, M., Home, W.C., Zhang, H., Yoshimura, A. and Baron, R. (1999) Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and UbcH7. J. Biol. Chem., 274, 31707-31712.
123. Yoon, C.H., Lee, J., Jongeward, G.D. and Sternberg, P.W. (1995) Similarity of sli-1, a regulator of vulval development in C.elegans, to the mammalian proto-oncogene c-Cbl. Science, 269, 1102-1105.
124. Zhang, D. et al. (1997) Neuregulin-3 (NRG3): a novel neural tissue-enriched protein that binds and activates ErbB4. Proc. Natl Acad. Sci. USA, 94, 9562-9567.
125. Zhang, K., Sun, J., Liu, N., Wen, D., Chang, D., Thomason, A. and Yoshinaga, S.K. (1996) Transformation of NIH 3T3 cells by HER3 or HER4 receptors requires the presence of HER1 and HER2. J. Biol. Chem., 271, 3884-3890.
126. Zrihan-Licht, S., Deng, B., Yarden, Y., McShan, G., Keydar, I. and Avraham, H. (1998) Csk homologous kinase, a novel signaling molecule, directly associates with the activated ErbB-2 receptor in breast cancer cells and inhibits their proliferation. J. Biol. Chem., 273, 4065-4072.